98 related articles for article (PubMed ID: 7529752)
1. Characterization of vasoactive intestinal peptide receptors in rabbit ciliary processes.
Horio B; Law NM; Rosenzweig SA
Invest Ophthalmol Vis Sci; 1995 Jan; 36(1):192-9. PubMed ID: 7529752
[TBL] [Abstract][Full Text] [Related]
2. Vasoactive intestinal peptide and intraocular pressure: adenylate cyclase activation and binding sites for vasoactive intestinal peptide in membranes of ocular ciliary processes.
Mittag TW; Tormay A; Podos SM
J Pharmacol Exp Ther; 1987 Apr; 241(1):230-5. PubMed ID: 3033201
[TBL] [Abstract][Full Text] [Related]
3. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
Zawilska JB; Niewiadomski P; Nowak JZ
Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
[TBL] [Abstract][Full Text] [Related]
4. [Autoradiographic localization and characterization of the ocular binding sites of the VIP (vasoactive intestinal peptide) in albino rats and rabbits].
Denis P; Dussaillant M; Elena PP; Nordmann JP; Rostene W; Laroche L
Ophtalmologie; 1990; 4(1):30-2. PubMed ID: 2174530
[TBL] [Abstract][Full Text] [Related]
5. Response and level of beta-adrenergic, vasoactive intestinal peptide, and PACAP receptors during the circadian cycle.
Hirota A; Kiuchi Y; Nii H; Gregory DS
Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1708-18. PubMed ID: 9286259
[TBL] [Abstract][Full Text] [Related]
6. Mutagenesis of N-glycosylation sites in the human vasoactive intestinal peptide 1 receptor. Evidence that asparagine 58 or 69 is crucial for correct delivery of the receptor to plasma membrane.
Couvineau A; Fabre C; Gaudin P; Maoret JJ; Laburthe M
Biochemistry; 1996 Feb; 35(6):1745-52. PubMed ID: 8639654
[TBL] [Abstract][Full Text] [Related]
7. Direct evidence for functional coupling of the vasoactive intestinal peptide receptor to Gi3 in native lung membranes.
Diehl NL; Kermode JC; Shreeve SM
Mol Pharmacol; 1996 Sep; 50(3):624-30. PubMed ID: 8794903
[TBL] [Abstract][Full Text] [Related]
8. Properties of vasoactive intestinal peptide-receptor interaction in rat liver membranes.
Guerrero JM; Prieto JC; Ramírez-Cárdenas R; Calvo JR; Goberna R
Rev Esp Fisiol; 1981 Mar; 37(1):1-8. PubMed ID: 6113623
[TBL] [Abstract][Full Text] [Related]
9. Identification of G proteins in lacrimal gland.
Meneray MA; Bennett DJ
Invest Ophthalmol Vis Sci; 1995 May; 36(6):1173-80. PubMed ID: 7730026
[TBL] [Abstract][Full Text] [Related]
10. Characterization and solubilization of vasoactive intestinal peptide receptors from rat lung membranes.
Provow S; Veliçelebi G
Endocrinology; 1987 Jun; 120(6):2442-52. PubMed ID: 3032591
[TBL] [Abstract][Full Text] [Related]
11. Site-directed mutagenesis of human vasoactive intestinal peptide receptor subtypes VIP1 and VIP2: evidence for difference in the structure-function relationship.
Nicole P; Du K; Couvineau A; Laburthe M
J Pharmacol Exp Ther; 1998 Feb; 284(2):744-50. PubMed ID: 9454823
[TBL] [Abstract][Full Text] [Related]
12. Distribution of vasoactive intestinal polypeptide (VIP) binding in circular muscle and characterization of VIP binding in canine small intestinal mucosa.
Mao YK; Barnett W; Coy DH; Tougas G; Daniel EE
J Pharmacol Exp Ther; 1991 Sep; 258(3):986-91. PubMed ID: 1653848
[TBL] [Abstract][Full Text] [Related]
13. Molecular basis and species specificity of high affinity binding of vasoactive intestinal polypeptide by the rat secretin receptor.
Holtmann MH; Hadac EM; Ulrich CD; Miller LJ
J Pharmacol Exp Ther; 1996 Nov; 279(2):555-60. PubMed ID: 8930157
[TBL] [Abstract][Full Text] [Related]
14. Cross-competition between vasoactive intestinal peptide and somatostatin for binding to tumor cell membrane receptors.
Virgolini I; Yang Q; Li S; Angelberger P; Neuhold N; Niederle B; Scheithauer W; Valent P
Cancer Res; 1994 Feb; 54(3):690-700. PubMed ID: 7905785
[TBL] [Abstract][Full Text] [Related]
15. Properties of the pituitary adenylate cyclase-activating polypeptide I and II receptors, vasoactive intestinal peptide1, and chimeric amino-terminal pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal peptide1 receptors: evidence for multiple receptor states.
Van Rampelbergh J; Gourlet P; De Neef P; Robberecht P; Waelbroeck M
Mol Pharmacol; 1996 Dec; 50(6):1596-604. PubMed ID: 8967982
[TBL] [Abstract][Full Text] [Related]
16. Characterization of vasoactive intestinal peptide receptors in retina.
Swedlund AP; Rosenzweig SA
Exp Eye Res; 1990 Sep; 51(3):317-23. PubMed ID: 2169429
[TBL] [Abstract][Full Text] [Related]
17. Characterization of vasoactive intestinal peptide (VIP) receptors in mammalian lung.
Dickinson KE; Schachter M; Miles CM; Coy DH; Sever PS
Peptides; 1986; 7(5):791-800. PubMed ID: 3025822
[TBL] [Abstract][Full Text] [Related]
18. Characterization of receptors for VIP on pancreatic acinar cell plasma membranes using covalent cross-linking.
McArthur KE; Wood CL; O'Dorisio MS; Zhou ZC; Gardner JD; Jensen RT
Am J Physiol; 1987 Mar; 252(3 Pt 1):G404-12. PubMed ID: 2435170
[TBL] [Abstract][Full Text] [Related]
19. High affinity vasoactive intestinal peptide receptors on fetal human nonpigmented ciliary epithelial cells.
Crook RB; Lui GM; Alvarado JA; Fauss DJ; Polansky JR
Curr Eye Res; 1994 Apr; 13(4):271-9. PubMed ID: 8033589
[TBL] [Abstract][Full Text] [Related]
20. Vasoactive intestinal peptide receptors on AR42J rat pancreatic acinar cells.
Raymond MJ; Rosenzweig SA
Biochem Biophys Res Commun; 1991 Aug; 179(1):176-82. PubMed ID: 1652948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]